The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their i...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Ferrari, C, Penna, A, Bertoletti, A, Cavalli, A, Valli, A, Schianchi, C, Fiaccadori, F
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 1989
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329792/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2529268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114299
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!